The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

3 Mar 2023 09:53

RNS Number : 8525R
Maven Income and Growth VCT 3 PLC
03 March 2023
 

Maven Income and Growth VCT 3 PLC (the Company)

 

Issue of Equity

 

On 7 October 2022, the Company launched an offer for subscription for new ordinary shares of 10p each (Ordinary Shares) to raise up to £5 million, with an over-allotment facility for up to a further £5 million (the Offer).

 

Pursuant to the Offer, a total of £4,641,849 of valid applications have been received in the period from 7 October 2022 up to close of business on 28 February 2023. In respect of the 2022/2023 tax year, £3,705,357 of valid applications were received in the period from 7 October 2022 up to 9.00am on 6 February 2023 and the Company issued and allotted 6,389,151 new Ordinary Shares on 8 February 2023. In the period from 6 February 2023 to close of business on 28 February 2023, in respect of the 2022/2023 tax year, £581,022 of valid applications were received, and, as a result, the Company has issued and allotted 982,796 new Ordinary Shares on 3 March 2023. In accordance with the allotment formula set out in the prospectus for the Offer, the offer prices at which these shares were issued were in the range of 57.90p to 58.84p per Ordinary Share and, as a result, the number of Ordinary Shares now in issue is 111,264,823. Therefore, the total number of voting rights in the Company is 111,264,823.

 

In respect of this allotment, an application will be made by the Company to the FCA and to the London Stock Exchange for the new Ordinary Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the new Ordinary Shares will become effective and dealings will commence on or around 7 March 2023.

 

The above statement of Voting Capital may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The Board of the Company intends that a final allotment in respect of applications for the 2022/2023 tax year will take place on or before 5 April 2023. It is also intended that an allotment in respect of applications for the 2023/2024 tax year will take place on or before 31 May 2023, unless the Offer is fully subscribed by an earlier date or extended, at the Board's discretion, to a date up to and including 6 October 2023.

 

For further information, please contact:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

 

3 March 2023

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFIFEAVIIVIIV
Date   Source Headline
25th Sep 201311:33 amRNSStatement re Proposed Joint Fund Raising
30th Aug 20133:34 pmRNSTransaction in Own Shares
29th Aug 20134:11 pmRNSTransaction in Own Shares
27th Aug 20133:56 pmRNSTransaction in Own Shares
23rd Aug 201312:42 pmRNSTransaction in Own Shares
22nd Aug 20133:07 pmRNSTransaction in Own Shares
20th Aug 20132:59 pmRNSTransaction in Own Shares
16th Aug 20132:53 pmRNSTransaction in Own Shares
15th Aug 20133:07 pmRNSTransaction in Own Shares
12th Aug 20131:21 pmRNSTransaction in Own Shares
15th Jul 20134:32 pmRNSHalf Yearly Report
18th Jun 20132:22 pmRNSChange of Registered Office
10th May 20135:59 pmRNSTransaction in Own Shares
7th May 20134:24 pmRNSTransaction in Own Shares
2nd May 20135:18 pmRNSDirector/PDMR Shareholding
2nd May 20135:16 pmRNSDirector/PDMR Shareholding
2nd May 20135:10 pmRNSDirector/PDMR Shareholding
2nd May 20135:04 pmRNSInterim Management Statement
1st May 20133:21 pmRNSResult of AGM
26th Apr 20132:57 pmRNSIssue of Equity
10th Apr 20133:11 pmRNSTransaction in Own Shares
9th Apr 201312:47 pmRNSTransaction in Own Shares
8th Apr 20131:52 pmRNSTransaction in Own Shares
8th Apr 20137:00 amRNSIssue of Equity
5th Apr 20136:14 pmRNSIssue of Equity
5th Apr 20134:54 pmRNSTransaction in Own Shares
5th Apr 201312:17 pmRNSDirector/PDMR Shareholding
4th Apr 20135:35 pmRNSDirector/PDMR connected person shareholding
4th Apr 20134:07 pmRNSTransaction in Own Shares
27th Mar 20137:00 amRNSAnnual Financial Report
5th Mar 20134:13 pmRNSIssue of Equity
11th Feb 20135:42 pmRNSOffer for Subscription - Update
23rd Jan 20135:03 pmRNSIssue of Equity
16th Nov 20123:02 pmRNSTransaction in Own Shares
15th Nov 20125:01 pmRNSTransaction in Own Shares
14th Nov 20123:21 pmRNSTransaction in Own Shares
5th Nov 20125:01 pmRNSIssue of Equity
30th Oct 20127:00 amRNSTransaction in Own Shares
30th Oct 20127:00 amRNSTransaction in Own Shares
25th Oct 20127:00 amRNSDirector/PDMR Shareholding
23rd Oct 201210:02 amRNSDirector/PDMR Shareholding
19th Oct 20122:15 pmRNSInterim Management Statement
17th Oct 20125:20 pmRNSResult of General Meeting
21st Sep 20122:17 pmRNSCirc re. Enhanced Buyback Scheme
13th Sep 20121:03 pmRNSStatement re Enhanced Buyback Scheme
23rd Aug 20126:30 pmRNSDirector/PDMR Shareholding
16th Aug 20125:00 pmRNSDirector/PDMR Shareholding
6th Aug 201212:00 pmRNSTransaction in Own Shares
13th Jul 20124:59 pmRNSHalf Yearly Report
31st May 20125:14 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.